background image

Paid Clinical Trials Cincinnati

Discover 1,259 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Recruiting
PHASE3

Sponsor:

Pfizer

Location:

Cincinnati, Huntington, Willoughby Hills, Willoughbyshow 93 more

Code:

NCT04173273

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Placebo

Endovascular Therapy for Low NIHSS Ischemic Strokes

Recruiting
PHASE2
PHASE3

Sponsor:

Emory University

Location:

Cincinnati, Lexington, Columbus, Bloomingtonshow 32 more

Code:

NCT04167527

Conditions

Cerebral Ischemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Immediate mechanical thrombectomy(iMT) using EmboTrap Revascularization Device

Initial medical management (iMM)

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

Recruiting
PHASE1
PHASE2

Sponsor:

Neuracle Genetics, Inc

Location:

Cincinnati, Toronto, Vancouver

Code:

NCT05984927

Conditions

Age-Related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

NG101 AAV gene therapy

A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting
PHASE2
PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Cincinnati, Columbus, Ann Arbor, Nashvilleshow 42 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

NO During CPB in Neonates to Reduce Risk of AKI

Recruiting
PHASE3

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Cincinnati

Code:

NCT04216927

Conditions

AKI

CHD - Congenital Heart Disease

Surgery

Eligibility Criteria

Sex: All

Age: 1 - 31

Healthy Volunteers: Not accepted

Interventions

Nitric Oxide

Oxygen

Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease

Recruiting
PHASE3

Sponsor:

Keryx Biopharmaceuticals

Location:

Cincinnati, Birmingham, Baltimore, Kansas Cityshow 9 more

Code:

NCT04523727

Conditions

Hyperphosphatemia Related to Chronic Kidney Disease

Eligibility Criteria

Sex: All

Age: 6 - 16

Healthy Volunteers: Not accepted

Interventions

ferric citrate

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Recruiting
PHASE1

Sponsor:

Pediatric Brain Tumor Consortium

Location:

Cincinnati, Chicago, Pittsburgh, Atlantashow 8 more

Code:

NCT04978727

Conditions

Medulloblastoma

Glioblastoma Multiforme

Anaplastic Astrocytoma

High-grade Astrocytoma NOS

Anaplastic Oligodendroglioma

Eligibility Criteria

Sex: All

Age: 1 - 21

Healthy Volunteers: Not accepted

Interventions

SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years

SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥1 and <10 years

SurVaxM for patients with non-relapsed DIPG post radiation-therapy ages ≥1 and ≤21 years

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Cincinnati, Columbus, West Chester, Bethesdashow 6 more

Code:

NCT06311227

Conditions

Recurrent Hairy Cell Leukemia

Recurrent Hairy Cell Leukemia Variant

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Magnetic Resonance Imaging

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Cincinnati, Franklin, Centerville, Ketteringshow 395 more

Code:

NCT04181060

Conditions

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bevacizumab

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

A Phase 2 Clinical Study in Children With HeFH Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing

Recruiting
PHASE2

Sponsor:

Esperion Therapeutics, Inc.

Location:

Cincinnati, Saint Louis, Winston-Salem, Hamiltonshow 6 more

Code:

NCT05694260

Conditions

Hypercholesterolemia

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Bempedoic acid